In view of the powerful spasmogenic actions of leukotrienes in vascular and bronchial tissue, AZD 4407 (ZD4407) block their biosynthesis by inhibiting 5-lipoxygenase may have therapeutic potential in a variety of inflammatory conditions including inflammatory arthropathies, asthma, psoriasis, and inflammatory bowel disease.